Product Images Clindamycin Phosphate

This is a description of Clindamycin Injection USP, a medication administered intravenously. It comes in a 50mL container with 12mg/mL concentration, containing Clindamycin phosphate, 2.5g dextrose hydrous, 2mg edetate disodium dihydrate, and water for injection. The medication should not be used in series connections, and the solution clarity checked for minute leaks. Dosage instructions can be found in the prescribing information. The medication is manufactured by Baxter Healthcare Corporation and stored at 20-25°C.*

This is a product description for a pharmaceutical product called "Clindamycin Injection USP in 5% Dextrose." The product comes in 50 mL single-dose containers, with a concentration of 600 mg per 50 mL, equivalent to 12 mg / mL. It is recommended to store the product at a temperature between 20° to 25°C (68° to 77°F), as indicated by the USP Controlled Room Temperature, and avoid temperatures higher than 30°. The container is made of PL 2501 Plastic and is manufactured by Baxter Healthcare Corporation in the USA, under the Galaxy and Novaplus trademarks.*

This is a prescription drug labeled as "Rx only" with National Drug Code (NDC) 43066-993-24 and Code 2G3466. The barcode position is Daly. It is for intravenous use and contains Clindamycin phosphate, dextrose hydrous, edetate disodium dihydrate, and Water for Injection, USP. The pH may have been adjusted with Sodium hydroxide and/or hydrochloric acid. It is not for rapid injection or intravenous push. Dosage information is available in the prescribing information. Supplementary medication must not be added, and it should not be used in series connections. Minute leaks and solution clarity should be carefully checked.*

Clindamycin Injection USP in 5% Dextrose is a medication used for Intravenous Use. It comes in a 50 mL Single Dose Container and contains Clindamycin phosphate, USP equivalent to 900 mg clindamycin, 2.5 g dextrose hydrous, USP, 2 mg edetate disodium dihydrate, USP, and Water for Injection, USP. It is cautioned to not add supplementary medication and must not be used in series connections. Store between 20°C to 25°C to avoid temperatures above 30°C. This medication is made by Baxter Healthcare Corporation and is Rx only. The dosage is mentioned in the prescribing information.*

The text describes a container of Clindamycin Injection USP in 5% Dextrose, which contains 12 single-dose containers each with 50 mL of the drug. The container is manufactured by Baxter Healthcare Corporation and is made in the USA. The container is registered under the trademark Galaxy by Baxter International Inc. and under the trademark Novaplus by Vizient Inc. It is recommended to store the container at temperatures between 20° to 25°C (68° to 77°F), and above 30°C should be avoided. The injection contains 900 mg per 50 ml (18 mg/mL).*

This is an Rx-only medication with NDC code 43066-995-24 and code 2G3467. The barcode position is specified for the same. The medication is for intravenous use and is sterile and nonpyrogenic. The medication is not suitable for rapid injection or IV push. The 50 mL solution has clindamycin phosphate, dextrose hydrous, edetate disodium dihydrate, and water for injection. The pH level may have been adjusted with sodium hydroxide and/or hydrochloric cid. It is advised not to add any more medication, must not be used in series connections and solution clarity should be checked for minute leaks. Dosage information is available in prescribing information.*